Product Information
LISDEXAMFETAMINE 30 MG CAPSULE is a generic product labeled by Alvogen Inc., priced at $3.0366 per EA under NDC 47781056401. Its NADAC has been published 143 times since Oct 4, 2023.
Strength
30 mg/1
Manufacturer
Alvogen Inc.NDC
47781056401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA214547On Market Since
8/25/2023
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has been published 143 times since Oct 4, 2023, and over the history we have for it it has declined 14.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0366 per EA |
|---|---|
| All-time high | $6.5077 (Apr 10, 2024) |
| All-time low | $2.9584 (Mar 18, 2026) |
| 52-week high | $3.9018 |
| 52-week low | $2.9584 |
| Median price | $3.9441 |
| Average price | $4.1703 |
| Largest weekly change | +59.1% (Jun 19, 2024) |
| Weeks tracked | 143 |
| Tracking since | Oct 4, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 30 MG CAPSULE, manufactured by Alvogen Inc., is $3.0366 per EA (NDC 47781056401), effective Jun 24, 2026.
How has the price of LISDEXAMFETAMINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has declined 14.8%. It has been tracked across 143 weekly CMS publications since Oct 4, 2023.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 30 MG CAPSULE?
Since Oct 4, 2023, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has ranged from a low of $2.9584 (Mar 18, 2026) to a high of $6.5077 (Apr 10, 2024), with a median of $3.9441 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 30 MG CAPSULE?
5 NADAC-published products share the same active ingredient, strength, and dosage form as LISDEXAMFETAMINE 30 MG CAPSULE, but none are currently priced below it.
Who manufactures LISDEXAMFETAMINE 30 MG CAPSULE?
LISDEXAMFETAMINE 30 MG CAPSULE (NDC 47781056401) is labeled by Alvogen Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification